NeuroPace (NPCE) Enterprise Value Growth (3y) (2023 - 2026)
NeuroPace (NPCE) Enterprise Value Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | NeuroPace | 518.90 Mn | 464.92 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.23% |
| Dec 31, 2025 | 7.60% |
| Sep 30, 2025 | 11.10% |
| Jun 30, 2025 | 12.39% |
| Mar 31, 2025 | 13.72% |
| Dec 31, 2024 | 23.01% |
| Sep 30, 2024 | 22.76% |
| Jun 30, 2024 | 24.28% |
| Mar 31, 2024 | -24.52% |
| Dec 31, 2023 | -20.40% |
| Sep 30, 2023 | -12.45% |
| Jun 30, 2023 | -85.25% |
| Mar 31, 2023 | -91.53% |